CompletedNot Applicable

HepC Micro-elimination on MSM and TGW Population.

Spain13,161 participantsStarted 2021-08-23

Plain-language summary

This is an observational study, in which a single visit will be carried out, which includes a questionnaire on sexual habits and in which the possibility of carrying out a screening for Hepatitis C will be offered. Depending on the score obtained in the questionnaire, the screening will be carried out using a rapid serology test or viral load. During the first year, a SCORE will be developed to classify the risk of positive results. This SCORE will be used during phase 2 to offer users of the centres a targeted screening based on the Pre-test score.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All BCN Checkpoint and BCN PreP·Point clients.
✓. 18 years and older.
✓. HIV uninfected or diagnosticated in the center in the last 7 days prior to the study inclusion.
✓. Men that have sex with men or transgender women.
✓. Signature of written consent form.
✓. Ability to comply with the requirements of the study protocol.

Exclusion criteria

✕. Knowledge of HIV infection from more than 7 days
✕. Knowledge of active HCV infection

What they're measuring

Hepatitis C active infection

Timeframe: August 2021 o September 2023

Trial details

NCT IDNCT06847958

SponsorProjecte dels NOMS Hispanosida

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Hepatitis C trials